Financials data is unavailable for this security.
View more
Year on year Medpace Holdings Inc grew revenues 29.17% from 1.46bn to 1.89bn while net income improved 15.26% from 245.37m to 282.81m.
Gross margin | 29.69% |
---|---|
Net profit margin | 17.66% |
Operating margin | 19.74% |
Return on assets | 20.48% |
---|---|
Return on equity | 54.06% |
Return on investment | 43.51% |
More ▼
Cash flow in USDView more
In 2023, Medpace Holdings Inc increased its cash reserves by 768.38%, or 217.18m. The company earned 433.37m from its operations for a Cash Flow Margin of 22.98%. In addition the company used 34.63m on investing activities and also paid 182.64m in financing cash flows.
Cash flow per share | 12.32 |
---|---|
Price/Cash flow per share | 26.94 |
Book value per share | 28.42 |
---|---|
Tangible book value per share | 5.94 |
More ▼
Balance sheet in USDView more
Current ratio | 0.9916 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼
Growth rates in USD
SmartText is unavailable
EPS growth(5 years) | 35.10 |
---|---|
EPS (TTM) vs TTM 1 year ago | 33.78 |